Pfizer’s COVID-19 Vaccine Protects Against SARS-CoV-2 Variants
Pfizer’s COVID-19 vaccine has been shown to protect against several SARS-CoV-2 variants, alleviating concerns that vaccines will become ineffective.
Related Articles
Online Event
In this webinar, Jeff Coller, PhD, will describe a new therapeutic technique that enhances mRNA translation. This technology has numerous clinical applications and works by…
Universal Vaccine Strategy Boosts Body’s RNAi Response to Viruses
Researchers say there is little chance of a virus mutating to avoid this vaccination strategy, which blocks viral ability to suppress host RNAi responses.
Universal Vaccine Strategy Boosts Body’s RNAi Response to Viruses
Researchers say there is little chance of a virus mutating to avoid this vaccination strategy, which blocks viral ability to suppress host RNAi responses.
Organoids Stand Out as Stand Ins in Drug Development
By capturing the genotypic and phenotypic heterogeneity of real tissues, organoids faithfully model human diseases and therapeutic responses.
Targets for Novel Cancer Immunotherapies Identified by Antibiotics
A new study shows tetracycline antibiotics help the immune system find cancer cells in a way that is different from current immunotherapies.
SPARDA: A Programmable Nucleic Acid Targeting Technology Like CRISPR
SPARDA and other systems that encode diverse effectors have the potential to offer a novel programmable tool for the field of biotechnology.
The State of Omics 2024, Wed, Apr 17th, 2024 @ 11:00 AM Mary Ann Liebert, Inc. publishers
The past two years have seen exciting advances in the world of genomics, as several companies threaten to disrupt the next-gen sequencing (NGS) establishment. Meanwhile,…
Launch of Nvelop Therapeutics for Delivery of Genetic Cargo, AACR Recap
On this week’s Touching Base podcast, the GEN editors discuss the launch of Nvelop Therapeutics, a new start-up leveraging approaches developed by gene editing pioneers David…
Getting Started with mRNA-Based Therapeutics
© 2024 Mary Ann Liebert, Inc. Publishers. All rights reserved.
The State of Omics 2024, Wed, Apr 17th, 2024 @ 11:00 AM Mary Ann Liebert, Inc. publishers
The past two years have seen exciting advances in the world of genomics, as several companies threaten to disrupt the next-gen sequencing (NGS) establishment. Meanwhile,…